scholarly journals Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)

BMC Cancer ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Florian Huemer ◽  
Josef Thaler ◽  
Gudrun Piringer ◽  
Hubert Hackl ◽  
Lisa Pleyer ◽  
...  
Keyword(s):  
Tp53 Mutations ◽  
Anti Vegf ◽  
Medikamentöse Tumortherapie

Intravitreale Anti-VEGF-Therapie mit Bevacizumab bei diabetischem Makulaödem

2006 ◽  
Vol 223 (S 2) ◽  
Author(s):  
D Kook ◽  
A Wolf ◽  
AS Neubauer ◽  
SG Priglinger ◽  
A Hofer ◽  
...  
Keyword(s):  
Anti Vegf

Anti-VEGF bei reiner Pigmentepithelabhebung

2007 ◽  
Vol 224 (S 1) ◽  
Author(s):  
L Spetlikova ◽  
O Rudolph ◽  
R Effert
Keyword(s):  
Anti Vegf
Sign in / Sign up

Export Citation Format

Share Document